Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L et al (2019) ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020(41):111–188
2. Ruscica M, Rizzuto AS, Corsini A (2022) Role of lipoprotein(a) in plaque progression. Eur Heart J Suppl 24:I72–I5
3. Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L et al (2022) Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J 43:3925–3946
4. Parhofer K, Laufs U (2023) Lipid profile and lipopotein(a) testing. Dtsch Arzteblatt Int 120:582–588
5. Shaw LJ, Blankstein R, Bax JJ, Ferencik M, Bittencourt MS, Min JK et al (2021) Society of Cardiovascular Computed Tomography / North American Society of Cardiovascular Imaging—expert consensus document on coronary CT imaging of atherosclerotic plaque. J Cardiovasc Comput Tomogr 15:93–109